Rodrigo Vazquez Guillamet to Humans
This is a "connection" page, showing publications Rodrigo Vazquez Guillamet has written about Humans.
Connection Strength
0.361
-
Vazquez Guillamet R, Rjob A, Bierhals A, Tague L, Marklin G, Halverson L, Witt C, Byers D, Hachem R, Gierada D, Brody SL, Takahashi T, Nava R, Kreisel D, Puri V, Trulock EP. Potential Role of Computed Tomography Volumetry in Size Matching in Lung Transplantation. Transplant Proc. 2023 Mar; 55(2):432-439.
Score: 0.044
-
Vazquez Guillamet R. Comments and opinions: Predicted total lung capacity equations: A barrier to the definition of safe lung size differences in lung transplantation. J Heart Lung Transplant. 2022 07; 41(7):996-997.
Score: 0.041
-
Vazquez Guillamet R. Before and beyond Inhaled Corticosteroids. Ann Am Thorac Soc. 2020 12; 17(12):1526-1528.
Score: 0.038
-
Vazquez Guillamet R. Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation. Medicina (Kaunas). 2019 Sep 26; 55(10).
Score: 0.035
-
Abukhalaf J, Davidson R, Villalobos N, Meek P, Petersen H, Sood A, Tesfaigzi Y, Vazquez Guillamet R. Chronic obstructive pulmonary disease mortality, a competing risk analysis. Clin Respir J. 2018 Nov; 12(11):2598-2605.
Score: 0.033
-
Vazquez Guillamet C, Hsu JL, Dhillon G, Vazquez Guillamet R. Pulmonary Infections in Immunocompromised Hosts: Clinical. J Thorac Imaging. 2018 Sep; 33(5):295-305.
Score: 0.032
-
Vazquez Guillamet R, Petersen H, Meek P, Sood A, Tesfaigzi Y. Grading Severity of Productive Cough Based on Symptoms and Airflow Obstruction. COPD. 2018 04; 15(2):206-213.
Score: 0.031
-
Vazquez Guillamet R, Petersen H, Meek PM, Tesfaigzi Y, Sood A. Normalization of FEV1/FVC Ratio to Greater Than 0.7 Does Not Equal Resolution of Disease. Am J Respir Crit Care Med. 2018 03 15; 197(6):834-835.
Score: 0.031
-
Vazquez Guillamet R, Ursu O, Iwamoto G, Moseley PL, Oprea T. Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records. Health Informatics J. 2018 12; 24(4):394-409.
Score: 0.028
-
Heiden BT, Yang Z, Bai YZ, Yan Y, Chang SH, Park Y, Colditz GA, Dart H, Hachem RR, Witt CA, Vazquez Guillamet R, Byers DE, Marklin GF, Pasque MK, Kreisel D, Nava RG, Meyers BF, Kozower BD, Puri V. Development and validation of the lung donor (LUNDON) acceptability score for pulmonary transplantation. Am J Transplant. 2023 04; 23(4):540-548.
Score: 0.011
-
Reynolds D, Vazquez Guillamet C, Day A, Borcherding N, Vazquez Guillamet R, Chore?o-Parra JA, House SL, O'Halloran JA, Z??iga J, Ellebedy AH, Byers DE, Mudd PA. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. J Immunol. 2021 09 01; 207(5):1229-1238.
Score: 0.010
-
Yang Z, Gerull WD, Shepherd HM, Marklin GF, Takahashi T, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Byers DE, Vazquez Guillamet R, Pasque MK, Yan Y, Kreisel D, Puri V. Different-team procurements: A potential solution for the unintended consequences of change in lung allocation policy. Am J Transplant. 2021 09; 21(9):3101-3111.
Score: 0.010
-
Terada Y, Gauthier JM, Pasque MK, Takahashi T, Liu J, Nava RG, Hachem RR, Witt CA, Byers DE, Vazquez Guillamet R, Kozower BD, Meyers BF, Aguilar PR, Kulkarni HS, Patterson GA, Kreisel D, Puri V. Clinical Outcomes of Lung Transplants From Donors With Unexpected Pulmonary Embolism. Ann Thorac Surg. 2021 08; 112(2):387-394.
Score: 0.009
-
Petersen H, Vazquez Guillamet R, Meek P, Sood A, Tesfaigzi Y. Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol. 2018 07; 59(1):13-17.
Score: 0.008